Alan Solomon
#138,418
Most Influential Person Now
Alan Solomon's AcademicInfluence.com Rankings
Alan Solomonphilosophy Degrees
Philosophy
#7108
World Rank
#10269
Historical Rank
Logic
#4183
World Rank
#5443
Historical Rank
Alan Solomonbiology Degrees
Biology
#9636
World Rank
#12861
Historical Rank
Biochemistry
#1485
World Rank
#1612
Historical Rank
Download Badge
Philosophy Biology
Alan Solomon's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biochemistry University of California, San Francisco
Why Is Alan Solomon Influential?
(Suggest an Edit or Addition)Alan Solomon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis (2005) (1202)
- CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS (1965) (933)
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004 (2005) (491)
- Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis (2012) (315)
- Transmissibility of systemic amyloidosis by a prion-like mechanism (2002) (284)
- Nephrotoxic potential of Bence Jones proteins. (1991) (273)
- Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. (1990) (256)
- SERUM HYPERVISCOSITY SYNDROME. (1965) (241)
- Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). (1982) (214)
- Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. (1992) (208)
- Amyloid deposits in transthyretin‐derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology (2005) (202)
- Antibody-mediated resolution of light chain-associated amyloid deposits. (2000) (187)
- Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. (1999) (182)
- Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. (1999) (172)
- Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations (2003) (158)
- Bence-Jones proteins and light chains of immunoglobulins. VII. Localization of antigenic sites responsible for immunochemical heterogeneity of kappa chains. (1972) (152)
- Plasmapheresis therapy in macroglobulinemia. (1962) (135)
- Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. (2001) (134)
- Thermodynamic Modulation of Light Chain Amyloid Fibril Formation* (2000) (129)
- METABOLISM OF BENCE JONES PROTEINS. (1964) (128)
- Clinical and experimental metabolism of normal 6.6s gamma-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. (1963) (124)
- Bence-Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves. (1969) (122)
- Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and VL Fragment (*) (1995) (118)
- Immunoglobulin heavy-chain-associated amyloidosis. (1990) (117)
- Characterization of systemic amyloid deposits by mass spectrometry. (2006) (113)
- Amyloidogenic potential of foie gras (2007) (109)
- Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light‐chain amyloid proteins (1994) (106)
- Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628. (2004) (102)
- A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. (1995) (101)
- Elicitation of allergic asthma by immunoglobulin free light chains. (2005) (99)
- Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. (2010) (88)
- Repertoire cloning of lupus anti-DNA autoantibodies. (1996) (87)
- Calcifying epithelial odontogenic (Pindborg) tumor-associated amyloid consists of a novel human protein. (2003) (87)
- Counteracting Effects of Renal Solutes on Amyloid Fibril Formation by Immunoglobulin Light Chains* (2001) (85)
- Treatment of advanced gastrointestinal cancer with 5‐fluorouracil and mitomycin C (1979) (81)
- TWO TYPES OF γ-MYELOMA PROTEINS, β2A-MYELOMA PROTEINS, γ1-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS (1963) (79)
- [6] Light chains of human immunoglobulins (1985) (78)
- Transgenic mouse model of AA amyloidosis. (1999) (76)
- Two different types of amyloid deposits—apolipoprotein A-IV and transthyretin—in a patient with systemic amyloidosis (2004) (76)
- Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. (2010) (71)
- Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. (2010) (71)
- Repertoire of Human Antibodies against the Polysaccharide Capsule of Streptococcus pneumoniaeSerotype 6B (1999) (70)
- Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. (1999) (70)
- Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins (2004) (69)
- Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition. (1994) (68)
- Self-association of human immunoglobulin kappa I light chains: role of the third hypervariable region. (1980) (68)
- Preferential expression of human lambda-light-chain variable-region subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia. (1994) (67)
- Expression of Odontogenic Ameloblast-Associated Protein (ODAM) in Dental and Other Epithelial Neoplasms (2008) (66)
- Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies. (2003) (63)
- Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis) (1995) (63)
- Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains (2008) (62)
- Immunohistologic localization of gamma-1-macroglobulins, beta-2A-myeloma proteins, 6.6 S gamma-myeloma proteins and Bence Jones proteins. (1963) (62)
- Diagnostic and Therapeutic Potential of Amyloid-Reactive IgG Antibodies Contained in Human Sera1 (2006) (60)
- Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. (2014) (59)
- Light chain-associated amyloid deposits comprised of a novel kappa constant domain. (1998) (59)
- Human immunoglobulin kappa light chain genes of subgroups II and III. (1985) (58)
- Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. (2008) (58)
- Induction in mice of human light-chain-associated amyloidosis. (1992) (57)
- Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. (2001) (56)
- A “monoclonal” type, low molecular weight protein related to γM-macroglobulins (1967) (56)
- Senile seminal vesicle amyloid is derived from semenogelin I. (2005) (55)
- Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. (2003) (55)
- “Acquired Agammaglobulinemia” with Auto‐Immune Hemolytic Disease: Graft‐versus‐Host Reaction? (1961) (55)
- Biology and therapy of immunoglobulin deposition diseases. (1997) (54)
- Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies. (1983) (53)
- Tertiary structure of human lambda 6 light chains. (1999) (52)
- Light chains of human immunoglobulins. (1985) (52)
- Odontogenic ameloblast-associated protein nature of the amyloid found in calcifying epithelial odontogenic tumors and unerupted tooth follicles (2008) (51)
- Idiotypic analysis of myeloma proteins: anti-DNA activity of monoclonal immunoglobulins bearing an SLE idiotype is more common in IgG than IgM antibodies. (1987) (51)
- Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. (1993) (51)
- Contribution of human VκII germ-line genes to light-chain diversity (1984) (50)
- Novel arrangement of immunoglobulin variable domains: X-ray crystallographic analysis of the lambda-chain dimer Bence-Jones protein Loc. (1985) (50)
- Unreliability of immunohistochemistry for typing amyloid deposits. (2008) (49)
- Antibodies elicited by pneumococcal antigens bear an anti-DNA--associated idiotype. (1991) (49)
- Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis (2017) (49)
- Light chains of immunoglobulins: structural-genetic correlates. (1986) (46)
- BENCE JONES PROTEINEMIA. (1964) (46)
- A cross-reactive idiotype on anti-DNA antibodies defines a H chain determinant present almost exclusively on IgG antibodies. (1989) (45)
- Bence Jones proteins: a powerful tool for the fundamental study of protein chemistry and pathophysiology. (1991) (44)
- Low-Molecular-Weight Proteins Related to Bence Jones Proteins in Multiple Myeloma (1966) (42)
- Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. (2007) (42)
- Amino acid sequence change associated with genetic marker Inv(2) of human immunoglobulin (1974) (42)
- Pathology of AA Amyloidosis in Domestic Sheep and Goats (2003) (41)
- Primary amyloidosis associated with a novel heavy‐chain fragment (AH amyloidosis) (1994) (41)
- Sequence similarities among kappa IIIb chains of monoclonal human IgM kappa autoantibodies (1984) (41)
- Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. (2006) (40)
- Molecular heterogeneity of immunoglobulin-M (gammaM-globulin). (1969) (39)
- Systemic AA Amyloidosis in the Common Marmoset (2005) (38)
- BENCE JONES PROTEINS AND LIGHT CHAINS OF IMMUNOGLOBULINS (1969) (38)
- Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. (2004) (38)
- Transient monoclonal gammopathy associated with cytomegalovirus infection. (1974) (37)
- Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers. (1994) (37)
- A molecular basis for nonsecretory myeloma. (2004) (35)
- Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb (1994) (34)
- Pathogenic anti-DNA antibodies in SLE: idiotypic families and genetic origins. (1990) (34)
- Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies. (2008) (33)
- A quantitative assay for IgA rheumatoid factor. (1982) (33)
- Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. (2006) (32)
- Serologically defined V region subgroups of human lambda light chains. (1987) (32)
- Micro-imaging of amyloid in mice. (2006) (31)
- Bence-Jones proteins and light chains of immunoglobulins (second of two parts). (1976) (31)
- SEQUENCE SIMILARITIES AMONG KIIIb CHAINS OF MONOCLONAL HUMAN IgMK AUTOANTIBODIES (1984) (31)
- Variable domain structure of kappaIV human light chain Len: high homology to the murine light chain McPC603. (1997) (31)
- Homogeneous (monoclonal) immunoglobulins in cancer. (1977) (30)
- Definition of Organ Involvement and Treatment Response in Primary Systemic Amyloidosis (AL): A Consensus Opinion from the 10th International Symposium on Amyloid and Amyloidosis. (2004) (30)
- Structural and functional properties of human lambda-light-chain variable-region subgroups (1995) (29)
- Biosynthesis of low molecular weight (7S) and high molecular weight (19S) immunoglobulin M. (1970) (28)
- Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma (2010) (28)
- Bence Jones proteins and light chains of immunoglobulins. IV. Immunochemical differentiation among proteins within each of the three established kappa-chain classes. (1971) (28)
- Micro-method to isolate and purify amyloid proteins for chemical characterization (2001) (28)
- Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro (2003) (28)
- Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis (2005) (27)
- Structure of a second crystal form of Bence-Jones protein Loc: strikingly different domain associations in two crystal forms of a single protein. (1989) (27)
- Structural and idiotypic characterization of the L chains of human IgM autoantibodies with different specificities. (1989) (27)
- Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. (1998) (26)
- Preferential expression of the systemic lupus erythematosus-associated idiotype 8.12 in sera containing monoclonal immunoglobulins. (1987) (26)
- Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis (2017) (26)
- Identification and characterization of a functional human Ig VλVI germline gene (1994) (26)
- Structural Bases of Light Chain-Related Pathology (1999) (26)
- A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding (2003) (26)
- Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review (2006) (26)
- Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules. (2010) (25)
- ODAM Expression Inhibits Human Breast Cancer Tumorigenesis (2011) (25)
- Anemia in macroglobulinemia. (1963) (24)
- Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma. (1967) (24)
- Monoclonal antibodies reactive with idiotypic and variable-region specific determinants on human immunoglobulins. (1984) (24)
- Bence Jones proteins: malignant or benign? (1982) (24)
- Human kappa light chain subgroup analysis with synthetic peptide-induced antisera. (1986) (23)
- Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies. (1990) (23)
- One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis (2019) (23)
- Diagnostic and Therapeutic Potential of Amyloid-Reactive IgG Antibodies Contained in Human Sera (2006) (22)
- Immunoglobulin-sulfated polysaccharide interactions. Binding of agaropectin and heparin by human IgG proteins (1981) (22)
- Phase 1a/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL Amyloidosis. (2021) (21)
- Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice. (2008) (21)
- Odontogenic Ameloblast Associated Protein as a Novel Biomarker for Human Breast Cancer (2009) (21)
- Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes (1978) (21)
- Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis (2015) (20)
- Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor. (1980) (20)
- Serologic and chemical differentiation of human lambda III light chain variable regions. (1991) (20)
- Bence-Jones proteins and light chains of immunoglobulins. V. X-ray crystallographic investigation of the amino-terminal half of a kappa Bence-Jones protein. (1970) (20)
- Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT. (1983) (20)
- A father and his son with systemic AL amyloidosis (2009) (19)
- Light Chain Variable Region Subgroups of Monoclonal Immunoglobulins in Amyloidosis AL (1986) (18)
- Monoclonal Immunoglobulins As Biomarkers Of Cancer (1980) (18)
- Inherent Anti-amyloidogenic Activity of Human Immunoglobulin γ Heavy Chains* (2009) (18)
- Luminescence studies on Bence-Jones proteins and light chains of immunoglobulins and their subunits. (1976) (18)
- Distinctive serologic, chemical, and molecular properties of human lambda IV light chains. (1995) (18)
- A Human Monoclonal IgG That Binds Aβ Assemblies and Diverse Amyloids Exhibits Anti-Amyloid Activities In Vitro and In Vivo (2015) (18)
- Human Anti-Aβ IgGs Target Conformational Epitopes on Synthetic Dimer Assemblies and the AD Brain-Derived Peptide (2012) (17)
- Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII. (1976) (17)
- A Hidden Antigenic Site Localized to the Constant Region of Light Chains of Immunoglobulins (1973) (16)
- Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope. (2007) (16)
- Activity of rheumatoid factors of different molecular sizes: comparison of autologous monomeric and polymeric monoclonal IgA rheumatoid factors. (1985) (15)
- Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy. (1975) (14)
- A perspective of plasma cell dyscrasias: Clinical implications of monoclonal light chains in renal disease (1988) (14)
- Immunohistochemical and Biochemical Evidence of Ameloblastic Origin of Amyloid-Producing Odontogenic Tumors in Cats (2013) (14)
- Variable‐region subgroup distribution among λ‐type immunoglobulins in normal human serum (1994) (14)
- Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling (2013) (14)
- Pitfalls of molecular replacement: the structure determination of an immunoglobulin light-chain dimer. (1996) (13)
- Characterization of a light chain product of the human JC lambda 7 gene complex. (1996) (13)
- Bence-Jones proteins and light chains of immunoglobulins (first of two parts). (1976) (13)
- Generation and Characterization of Anti-AA Amyloid-Specific Monoclonal Antibodies (2011) (13)
- Hereditary amyloidosis [2] (multiple letters) (2002) (13)
- Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis (2016) (13)
- Bence Jones proteins and light chains of immunoglobulins. 3. Inv antigenicity: a genetic expression with serologic dependency of the intact kappa light chain molecule. (1970) (13)
- Chemical and serologic characterization of human lambda VIII light chains. (1994) (13)
- Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. (1994) (12)
- Ominous consequences of immunoglobulin deposition. (1993) (12)
- Flow cytometric characterization of amyloid fibrils. (1999) (12)
- Apolipoprotein E genotypes in AA and AL amyloidoses (1995) (12)
- Immunochemical classification of nonisolated light chains of immunoglobulins. (1974) (12)
- Serologic crossreactions among primate immunoglobulins. (1995) (11)
- Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups. (1993) (11)
- Nephritogenic λ Light Chain Dimer: A Unique Human Miniautoantibody Against Complement Factor H (1999) (10)
- Immunogenic and antigenic epitopes of Ig. XXV. Monoclonal antibodies that differentiate the Mcg+/Mcg- and Oz+/Oz- C region isotypes of human lambda L chains. (1988) (10)
- Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins. (1976) (10)
- Bence Jones proteins and light chains of immunoglobulins. VI. Immunochemical detection of interclass similarities among kappa-chains. (1971) (10)
- Al Amyloidosis in a Patient with a T60a Ttr Mutation (2007) (10)
- Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis (2011) (10)
- The Amyloid-Reactive Monoclonal Anitbody 11-1F4 Binds a Cryptic Epitope on Fibrils and Partially Denatured Immunoglobulin Light Chains and Inhibits Fibrillogenesis (2004) (9)
- Bence Jones Proteins and Light Chains of Immunoglobulins XIV. (1976) (9)
- AA amyloidosis associated with a mutated serum amyloid A4 protein (2009) (9)
- Misclassification of amyloidosis is unwarranted. (2006) (9)
- Familial Amyloidosis Associated with a Novel Mutation (D68g) in the Lysozyme Gene (2007) (9)
- Association of human lambda light chain V/J/C segments: serologic analysis and primary structure of the lambda VI Bence Jones protein THO. (1986) (9)
- Splenic plasma cells can serve as a source of amyloidogenic light chains. (2009) (9)
- Conformational dependency of human IgG heavy chain-associated Gm allotypes. (1993) (9)
- AA amyloidosis induced in sheep principally affects the gastrointestinal tract. (2009) (9)
- Experimental model of human light-chain-associated disease. (1992) (8)
- Chemical typing of porcine systemic amyloid as AA-amyloid (2005) (8)
- Cellular Regulation of Humoral Immunity (1975) (8)
- 18F Florbetapir PET/CT cardiac amyloid imaging in patients with systemic amyloidosis (2013) (7)
- Characterization and preliminary crystallographic data on the VL-related fragment of the human kI Bence Jones protein Wat. (1981) (7)
- Nephritogenic l Light Chain Dimer: A Unique Human Miniautoantibody Against Complement Factor H (1999) (7)
- Structural studies of an Inv (1, −2) kappa light chain (1974) (7)
- Molecular characterization of a human V ?VIII germline gene (1995) (7)
- Human lambda light-chain constant region gene CMor lambda: the primary structure of lambda VI Bence Jones protein Mor. (1985) (7)
- Identification and characterization of a functional human Ig V lambda VI germline gene. (1994) (7)
- Production of Amyloidogenic Peptides from Human Immunoglobulin Light (L)-Chains (1991) (6)
- Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains. (2011) (6)
- Subacute hepatitis in Waldenstrom's macroglobulinemia. (1963) (6)
- Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein. (1978) (6)
- Development and evaluation of agents for targeting visceral amyloid. (2011) (6)
- Immunoglobulin disturbances and their clinical significance. (1973) (6)
- Erratum: Transmissibility of systemic amyloidosis by a prion-like mechanism (Proceedings of the National Academy of Sciences of the United States of America (May 14, 2002) 99: 10 (6979-6984)) (2003) (6)
- Definition of organ involvement and treatment response in primary systemic amyloidosis (AL) (2004) (5)
- IgG Conformer's Binding to Amyloidogenic Aggregates (2015) (5)
- Response of metastatic malignant carcinoid tumor to adriamycin (NSC-123127). (1976) (5)
- Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma. (1977) (5)
- Radioimaging of primary (AL) amyloidosis with an amyloid-reactive monoclonal antibody (2004) (4)
- Molecular Heterogeneity of Immunoglobulin-M (γM-Globulin) (1969) (4)
- Immunoglobulin on the surface of human lymphocytes. The detection of kappa chain V region determinants on B cells and not on T cells. (1973) (4)
- Light chain deamidation in AL𝛌 amyloid-associated proteins (2011) (4)
- Monoclonal antibodies against human anti-F(ab')2 antibodies react with light chain epitopes. (1991) (4)
- The essentiality of decyclization of pyrrolidonecarboxylic acid prior to utilization in protein biosynthesis. (1971) (4)
- A "monoclonal" type, low molecular weight protein related to gamma-M-macroglobulins. (1967) (4)
- Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodies. (1986) (3)
- Bence Jones proteins and light chains of immunoglobulins--XVII. Unique susceptibility of certain kappa-chains to proteolysis by human granulocyte-derived neutral proteases. (1978) (3)
- Renal Diseases Associated With Multiple Myeloma and Related Plasma Cell Dyscrasias (2004) (3)
- cis-Dichlorodiammineplatinum(II) and hexamethylmelamine in the treatment of non-oat cell lung cancer: a pilot study of the Southeastern Cancer Study Group. (1979) (3)
- Contribution of human V kappa II germ-line genes to light-chain diversity. (1984) (3)
- Identification and characterization of a human Vλ5 (T1) germline gene that encodes structurally unique λ light chains (1997) (3)
- Crystallographic data on a complete κ-type human Bence-Jones protein (1978) (3)
- Non-hereditary apolipoprotein AI-associated pulmonary amyloid (2011) (3)
- Preliminary crystallographic data on the human λIII Bence Jones protein dimer Cle (1981) (3)
- TWO TYPES OF gamma-MYELOMA PROTEINS, beta(2A)-MYELOMA PROTEINS, gamma(1)-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS. (1963) (3)
- Determination of cardiac amyloid involvement using 18F Florbetapir and dynamic PET (2013) (2)
- Semenogelin I is the Amyloidogenic Protein in Senile Seminal Vesicles (2004) (2)
- Hereditary amyloidosis. (2002) (2)
- Nuclear Odontogenic Ameloblast-Associated Protein (ODAM) Correlates with Melanoma Sentinel Lymph Node Metastasis (2013) (2)
- Equine light-chain-associated amyloidosis (1996) (2)
- ODONTOGENIC FELINE AND CANINE TUMOR-ASSOCIATED AMYLOID IS FORMED FROM AMELOBLASTIN (2008) (2)
- Amyloidogenic Region of Odontogenic Ameloblast Associated Protein (Odam) (2007) (2)
- Personalizing Amyloidosis Therapy with Real Time PET Imaging of Fibril-Reactive Monoclonal Antibody Cael-101 (2018) (2)
- Saa4-Related Aa Amyloidosis (2007) (2)
- A Micro-SPECT/CT System for Imaging of AA-Amyloidosis in Mice (2005) (1)
- Pindborg tumor-associated amyloid proteins (2004) (1)
- TWO TYPES OF y-MYELOMA PROTEINS , P 2 A-MYELOMA PROTEINS , yl-MACROGLOBULINS (1)
- Do VL genes have prognostic relevance (2003) (1)
- Renal Apolipoprotein A-I Amyloidosis (Aapo-A-I) Associated with a Novel Mutant Leu64Pro (2004) (1)
- Bence Jones protein: a molecular entity for studies on the structural and genetic control of antibody specificity. (1970) (1)
- Bence Jones proteins: Powerful tool for fundamental study of protein chemistry and pathophysiology (1991) (1)
- Identification and characterization of a human Vlambda5 (T1) germline gene that encodes structurally unique lambda light chains. (1997) (1)
- Molecular characterization of a human V lambda VIII germline gene. (1995) (1)
- IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER LOI FROM A HUMAN PATIENT (1999) (1)
- Molecular localization of human IgG anti-F(ab′)2 reactivity with variable- and constant-region λ light-chain epitopes (1995) (1)
- Some aspects of kidney involvement in plasma cell dyscrasias: A forum (1988) (1)
- Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE. (1986) (1)
- Role of Light Chain Deamidation in the Pathogenesis of Al Amyloidosis (2007) (1)
- Experimental Production of Human Amyloidosis AL (1991) (1)
- Abstract 92: Odonogenic Ameloblast Associated Protein (ODAM) moderates cell growth and invasion in the human breast cancer line MDA-MB-231 in part through the TGF-β signaling pathway (2012) (1)
- Detection and Identification of Amyloid Deposition Associated with Human Unerupted Tooth Follicles (2007) (0)
- Nature of os labrum-associated amyloid deposits (2011) (0)
- Animal Model Transgenic Mouse Model of AA Amyloidosis (1999) (0)
- Vesicular senile systemic amyloidosis (2011) (0)
- Abstract 4302: Odontogenic ameloblast-associated protein (ODAM) alters the growth and migration of human melanoma cells (2012) (0)
- Apolipoprotein a-I (Apo a-I) Nature of Knee Joint Meniscus-Associated Amyloid (2007) (0)
- Human Sera Amyloid-Reactive IgG Antibodies Contained Diagnostic and Therapeutic Potential of (2006) (0)
- [Antigenic determinants of the constant region of human immunoglobin kappa-chain detected by monoclonal antibodies]. (1989) (0)
- Radioimmunoimaging of AL amyloidosis (2010) (0)
- Knockdown of Pathologic Immuoglobulin Light Chain Protein by Small Interfering RNA Molecules. (2009) (0)
- A novel antibody light chain dimer: Implications for T-cell receptor structure (1989) (0)
- Human Immunoglobulin Heavy Chains Have Novel Fibril-binding And Anti-amyloidogenic Activity (2009) (0)
- Definitive Identification of Amyloid Deposits by Mass Spectrometry (2007) (0)
- Apolipoprotein A-IV codeposited with transthyretin in senile systemic amyloidosis (2001) (0)
- IgG anti-F(ab')2 antibodies from SLE patients react with immunodominant residues in kappa CDRs, but show reduced C kappa region reactivity. (1995) (0)
- Quantitative microSPECT/CT imaging of early onset spontaneous AA amyloidosis in H2/huUL-6 transgenic mice (2008) (0)
- IgG Conformer's Binding to Amyloidogenic Aggregates Please share how this access benefits you. Your story matters (2015) (0)
- P2-349: Naturally occurring human antibodies bind to fibril-related epitopes on purified cross-linked Aβ oligomers (2008) (0)
- Diagnostic et potentiel therapeutique de produits d'immunoglobuline intraveineuse (igiv) (2006) (0)
- M proteins in cancer (1978) (0)
- Peptide Phage Display and Epitope Mapping of a Fibril-Related Conformational Epitope Recognized by the 11-1f4 Monoclonal Antibody (2007) (0)
- Radioimmunoimaging of cardiac amyloid deposits in AL amyloidosis patients (2011) (0)
- Localized Al Amyloidosis: A DISTINCTIVE CLINICOPATHOLOGIC DISORDER (2007) (0)
- Physiopathological aspects of plasma cell dyscrasias: A forum (1988) (0)
- Radioimmunoimaging of amyloid deposits in AL amyloidosis (2012) (0)
- Cloned human IgG antibodies that bind oligomeric Aβ (2010) (0)
- Systemic Equine AL Amyloidosis (2004) (0)
- Imaging the biodistribution of systemic AA amyloidosis in mice using 125I-labeled protamine (2010) (0)
- Misclassification of amyloidosis is unwarranted. Authors' reply (2006) (0)
- Glycosylated Amyloid and Non-Amyloid Associated Lambda Light Chains (2007) (0)
- Phase I clinical PET imaging of AL amyloid using an 124I-labeled amyloid-reactive monoclonal antibody. (2009) (0)
- Oral methyl CCNU (MeCCNU) and prednisone (P) in previously treated multiple myeloma (MM) (1976) (0)
- IgG Anti-F(ab′)2 Antibodies from SLE Patients React with Immunodominant Residues in κ CDRs, but Show Reduced Cκ Region Reactivity (1995) (0)
- Chapter 14 AMicro-SPECT / CTSystemfor ImagingofAA-Amyloidosis in Mice (2006) (0)
- Imaging Human Al Amyloid in Mice Using the Fibril-Reactive Monoclonal Antibody 11-1f4 (2007) (0)
- Clinical Evaluation of Immunoglobulin Free Light Chain ELISA for Early Diagnosis of Multiple Myeloma (2006) (0)
- Medullary Thyroid Carcinoma-Associated Amyloid is Comprised of Calcitonin Gene-Related Peptide II (2004) (0)
- Light chain nephrotoxicity: A forum (1988) (0)
- Enzyme-linked immunosorbent assay for variable region λ VI subgroup of light chain in serum (1994) (0)
- HisTOChemical-Based Staging System for Al Amyloidosis (2007) (0)
- Foie Gras is a Dietary Source of Aef (2007) (0)
- Constant domain epitope expression of human immunoglobulin L chains of the κ and λ type in proteins of different variable subgroups (1989) (0)
- Immunoglobulin heavy-chain-associated amyloidosis ( amyloid / heavy-chain disease / immunoglobuiin genes / deletion mutant / amino acid sequence ) (0)
- In Vitro Silencing Of Amyloidogenic Lambda 6 Light Chain Production (2007) (0)
- Crystallographic data on a complete kappa-type human Bence-Jones protein. (1978) (0)
- Identification of Novel Inhibitors of Light Chain Fibrillogenesis (2007) (0)
- Sundries on therapy of multiple myeloma and amyloidosis and their renal consequences: A forum (1988) (0)
- Therapeutic Potential of naturally Occurring Fibril-Reactive Human Antibodies for Al Amyloidosis (2007) (0)
- STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL (2000) (0)
- An additional apolipoprotein in ATTR-amyloid (2001) (0)
- Immunotherapy of AL Amyloidosis (2004) (0)
- STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO (2000) (0)
- Preliminary crystallographic data on the human lambda III Bence Jones protein dimer Cle. (1981) (0)
- Editorial: Cellular regulation of humoral immunity. (1975) (0)
- Advances in Non-Invasive Imaging of Aa Amyloid in Mice (2007) (0)
- Molecular Diagnosis of Amyloidosis (2006) (0)
- Quantitative analysis of amyloid mass by segmentation of microPET and CT images (2009) (0)
- Fibrillogenesis and therapy of amyloidosis: an equilibrium approach (2003) (0)
- Extramedullary Production of Al Amyloid Precursor Protein (2007) (0)
- Biodistribution of a novel radiolabeled fibril-reactive monoclonal antibody in patients with systemic light chain (AL) amyloidosis (2010) (0)
- Kappa chain (V kappa III) subgroup-related activity in an idiotypic anti-cold agglutinin serum. (1976) (0)
- [Study of the antigenic structure of human immunoglobulin lambda-chain using monoclonal antibodies]. (1990) (0)
- Structural Localization of Light Chain Amyloidogenicity (2004) (0)
- Occurrence of prostaglandin D synthase in urine of patients with immunoglobulin light chain amyloidosis (AL amyloidosis) (1996) (0)
- Assessment of a monoclonal antibody-based free light chain enzyme-linked immunosorbent assay (ELISA) and the polyclonal antibody-based Freelite assay in AL amyloidosis (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alan Solomon?
Alan Solomon is affiliated with the following schools:
